O
The startup is developing an open-stent heart valve for transcatheter mitral and tricuspid valve replacement, providing a non-invasive solution for patients at surgical risk. This technology addresses the challenges of anatomical variations in the mitral space, such as sizing issues due to dilated ventricles, by offering a flexible device tailored to individual patient needs.
Dury, France
Updated 2 months ago
Funding
$3.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup is developing an open-stent heart valve for transcatheter mitral and tricuspid valve replacement, providing a non-invasive solution for patients at surgical risk. This technology addresses the challenges of anatomical variations in the mitral space, such as sizing issues due to dilated ventricles, by offering a flexible device tailored to individual patient needs.